Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases over time

Authors:
  • JCJ.M. Carrascosa
    J.M. Carrascosa
  • NRN. Rivera
    N. Rivera
  • IGI. Garcia-Doval
    I. Garcia-Doval
  • GCG. Carretero
    G. Carretero
  • FVF. Vanaclocha
    F. Vanaclocha
  • EDE. Daudén
    E. Daudén
  • PDP. De-La-Cueva-Dobao
    P. De-La-Cueva-Dobao
  • EHE. Herrera-Ceballos
    E. Herrera-Ceballos
  • IBI. Belinchón
    I. Belinchón
  • MAM. Alsina
    M. Alsina
  • JSJ.L. Sánchez-Carazo
    J.L. Sánchez-Carazo

Abstract
No abstract available
Keywords
Funding Information
  • Abbott Pharmaceuticals
  • Agencia Española de Medicamentos y Productos Sanitarios

This publication has 9 references indexed in Scilit: